Inpatient Glycemic Management 2011: Rationale and Strategies
Michelle F. Magee, MD
Associate Professor of Medicine
Georgetown University School of Medicine
MedStar Diabetes and Research Institutes
Uncontrolled hyperglycemia in the inpatient setting is a common occurrence and is clearly associated with an increase in adverse outcomes including morbidity, mortality, and increased costs. Hospital hyperglycemia in nonpregnant adults may be due to known type 1 or type 2 diabetes, previously unrecognized diabets, and/or stress associated with illness and hospitialization. Barriers contributing to suboptimal glycemic control in the inpatient setting are multifactorial and include deficits in knowledge regarding insulin requirements in health and in illness, prescribing, adjusting, and/or administering an insuling regimen tailored to acute care setting needs; fear of inducing hypoglycemia and lack of effective processes/protocols for implementing glycemic management stratagies hospital-wide. This video will support clinicians seeking to optimize hyperglycemia management protocols by applying current hyperglycemia management recommendations and stratagies to clinical practice. Dr. Michelle Magee reviews the prevalence and impact of hyperglycemia in the hospitalized patient; the evidence for implementing glycemic control; the latest clinical recommendations, stratagies, and protocols for impatient insulin management; and effective discharge planning which facilitates a smooth transition from hospital to the outpatient setting.
Method of Participation and Evaluation
To participate in this CME activity, please read the following information and click “Launch Program” at the bottom of this page. The activity may be evaluated online or by downloading the evaluation form by clicking the appropriate button at the bottom of this page. An added benefit of evaluating online is that you may print your certificate immediately after completion of the evaluation. Please note: To view this program you need a computer with an Internet browser and audio and video capabilities.
Up to 1 AMA PRA Category 1 Credit™
This activity is designed for physicians and allied health providers who care for patients with hospital hyperglycemia, including cardiologists, critical care physicians, endocrinologists, hospitalists, intensivists, internists, nurses, pharmacists, and diabetes educators.
After taking part in this CME activity, participants should be able to:
- Describe the prevalence, impact, and etiology of hyperglycemia in hospitalized patients
- Interpret the evidence for implementing glycemic control in hospitalized patients
- Apply the latest clinical recommendations, strategies, and protocols for insulin management in the inpatient setting
- Create a discharge plan for hospitalized patients with hyperglycemia that allows for continuum of care following discharge
Michelle F. Magee, MD
Michelle F. Magee, MD, has served as a consultant to sanofi-aventis and Tethys Bioscience, Inc., and has received research support from Edwards Lifescience Corporation/DexCom, Inc., Eisai Inc., sanofi-aventis, and Takeda Pharmaceuticals North America, Inc.
The Foundation for Improving Patient Outcomes staff and the independent peer reviewer report nothing to disclose.
CME Credit Designations
ACCME The Foundation for Improving Patient Outcomes (FFIPO) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA FFIPO designates this educational activity for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
AOA This activity is eligible for up to 1 hour of credit in Category 2-A of the American Osteopathic Association.